Philip Morris
the Causes of Cancer: Quantitative Estimates of Avoidable Risks of Cancer in the United States Today
Fields
- Author
- Doll, R.
- Peto, R.
- Area
- LEGAL DEPT/CARLSTADT
- Type
- PSCI, PUBLICATION SCIENTIFIC
- ABST, ABSTRACT
- BIBL, BIBLIOGRAPHY
- CHAR, CHART, GRAPH, TABLE, MAPS
- ABST, ABSTRACT
- Site
- N28
- Request
- Stmn/R1-004
- Named Organization
- Ny Tumor Registry
- Office of Technology Assessment
- Oxford Univ Press
- Populations Division
- Surveillance Epidemiology End Results Se
- US Congress
- Biometry Branch
- Bureau of the Census
- Ct Tumor Registry
- Natl Heart Lung + Blood Inst
- NCI, Natl Cancer Inst
- Office of Technology Assessment
- Named Person
- Fensterheim, R.
- Godwin, V.
- Gray, R.
- Harwood, C.
- Peto, R.
- Rogot, E.
- Stratton, I.
- Godwin, V.
- Document File
- 2025030516/2025030772/Doll & Hill
- Litigation
- Stmn/Produced
- Author (Organization)
- Green College Oxford
- Imperial Cancer Research Fund
- Jnci
- Radcliffe Infirmary
- Univ of Oxford
- Imperial Cancer Research Fund
- Master ID
- 2025030542/0660
Related Documents: - Characteristic
- MARG, MARGINALIA
- Date Loaded
- 05 Jun 1998
- UCSF Legacy ID
- dbe35e00
Document Images
1202 Doll and Peto
currence is nearly always recorded, at least in middle
age, for it is nearly always fatal. It is much more
difficult to be sure about changes in the incidence of
many other types of cancer. The common basal cell
carcinomas of the skin, for example, are also easy to:
diagnose but are often not registered at all~ as they
seldom cause death~ and may be treated effectively
outside the hospital. What appears to be a change in
incidence may, therefore, be a change only in the
completeness of registration. Cancer of the pancreas, by
contrast, i's almost always fatall but is easily misdiag-
nosed, perhaps as cancer of some other organ, unless it
is specially looked for. What appears to be an increased
incidence may, therefore, be wholly or partly due to
improvements im diagnosis, in the availability of medi-
cal services, or (as for all other types of cancer) in the
readiness of physicians to inform cancer registries of
any cancers they find! Such changes are particularly,
likely to affect the cancer incidence rates recorded for
people over 65 years of age; as many terminally ill old
people used not to be intensively investigated (some-
times, it must be admitted, to their advantage).
As most cancers are commoner among the old than
among the young, these spurious changes in ol& age
are liable to distort overall rates quite considerably and'
(if attention is not restricted to people under 65 years
of age) may conceal a stable or even a decreasing
incidence at younger ages at which cancer has been
reasonably well diagnosedl for several decades. Despite
these difficulties, some changes during periods when
no large improvements in relevant diagnostic tech-
nology were introduced have been so gross that there
can be no doubt about their reality. These changes
include the increase in esophageal cancer in the black
populatiom of South Africa, the continued increase in
lung cancer throughout most of the world, the increase
in mesothelh'oma of the pleura in males in indus-
trirali¢ed' countries, and the decrease in cancer of the
tongue in Britain and in cancers of the cervix ute6 and~
stomach throughout Western Europe and North Amer-
ica. Worldwide changes in the mortality attributed to
cancers of the lung and stomach in the last 25 years are
given in table 5. Detailed U.S. data for these and many,
other types of cancer are discussed in section 4.1 and im
appendixes C, D, and E.
2.4 Identitication of Causes
The simplest evidence of the preventability of cancer
would be the demonstration by scientific experiment
that a particular action actually leads to a reduction im
the incidcnce of the disease. Even .+,here such evidence
could in principle have been sought by means of
randomized! trials, this has not in general been done;
and so we often have to be content with the type of
strong circumstantial evidence that would be sufficient
to obtain a conviction in a court of law. Action, based
on such evidence, has in practice oftvn been followed
by the desired result-for example, a reduction in the
incidence of bladder c:utcer in the chcntical industry
has bec-n seen since stoplring the ntanulacture and use
TABLE 5.-International changes since 1950 in death certification
rates for cancers of stomach and hrng
Cou ntry
Period Percent change in
mortality' from,
cancer of:
Stomach Lung
Australia 1950-51 to: 1975 -53 +146
Austria 1952-53 to : 1976 -53 -8
Chile 1950-51 to 1975 -56 +38
Denmark 1952-53 to ~1976 -62 +87
England and Wales 1950-51 to 1975 -49 +33
West Germany 1952-53 to ~1975 -50 +36
Ireland 1950-51 to~1975 -54 +177
Israel 1950-51 to 1975 -49 +58
Japan 1950-51 to 1976 -37 +408
The Netherlands 1950-51to 1976 -60 +89
New Zealand 1950-51 to 1975 -54 +137
Norway 1952-53 to 1975 -59 +118
Scotland 1950-51 to ~ 1975 -46 +44
Switzerland 1952-53 to 1976 -64 +72
United States 1950-51to 1975 -61 +148
° Average of a and 9 rates at ages 35-84 yr. standardize&
for age as in IARC' (1976).
of 2-naphthylamine, while the progressive increase in
lung cancer risk that regular cigarette smokers suffer is
avoided byy people who give up the habit of smoking.
Cancer research workers throughout the world have
therefore accepted that the type of human evidence that
has been obtained, sometimes but by no means invari'r
ably (see section 4.2)~combined with laboratory evidence
that some suspect agent is carcinogenic in animals, is
strong enough to j,ustify the conclusion that a means of
avoiding some cases of human cancer has been iden-
tified. There are, of course, many borderline instances.
where reasonable differences of opinion exist, while
even for the well-established causes a few critics can
always be found who will argue that causality is not
established. A majorityy of students of the subject are
agreed that a few d'ozen agents or circumstances have
al'ready been shown to cause or prevent cancer in
humans and that, in a number of other instances, the
conditions that give rise to an increased incidence of
cancer have been cl'osely defined without a specific
agent having yet been identified (IARC Working Group,
1980). These agents an& conditions are listed in table 6.
Exposure to some agents, it will be noted, has been on
only a small scale, as in the case of a drug introduced
briefly for the treatment of a rare disease, whereas
exposure to others has been intensive and widespread,
and hundreds of thousands of cancers have been caused
each year. The extent to which these liste& agents and
conditions are now affecting the incidence of cancer in
the United States is discussed in Section 5.
2.5 Role of Genetic Factors, Luck, and Age
Some people of a given age will: develop cancer in
the near future,, and some will not. The deterntinants
of'who will and who will non develop cancer are best
tlividtd into three catef;ories not only thc usual
J"(4 Vt,t.. fk,: NO 6: JU:.t, t9Ht

Avoidable Risks of Cancer In the U.S. 1203
TABLE 6.-Established human carcinogenic agents and eireumstanees°'D
Agent or circumstance
Exposure'
Occupa- Medical Social
tional
Aflatoxin
Alcoholic drinks
Alkylating agents:
Cyclophosphamide
Melphalan
Aromatic amines:,
4-Aminodiphenyl +
Benzidine +
2-Naphthylamine +
Arsenic°' +
Asbestos +
Benzene +
Bis(chloromethyl) ether +
Busulphan
Cadmium° +
Chewing (betel, tobacco, lime)
Chromium +
Chlornaphazine.
Furniture manufacture (hardwood) +
Immunosuppressive drugs
Ionizing radiations' +
Isopropyl alcohol manufacture +
Leather goods manufacture +
Mustard gas +
Nickeld +
Estrogens:
Unopposed
Transplacental (DES )~
Overnutrition (causing obesity)
Phenacetin
Polycyclic hydrocarbons +
Reproductive history:
Late age at 1st pregnancy
Zero or low parity
Parasites:
Schislosoma haematobium
Chlonorchis sinensis
Sexual promiscuity
Steroids:
Anabolic (oxymetholone).
Contraceptives
Tobacco smoking
UV light +
Vinyl chloride +
Virus (hepatitis B)
+ Liver
+
Site of cancer
Mouth, pharynx,Jarynx, eosphagus, liver
+ Bladder
+ Marrow
Bladder
u
k
+ Skin, lung
Lung, pleura, peritoneum
Marrow
Lung
+ Marrow
Prostate
+ Mouth
Lung
+ Bladder
Nasal sinuses
+ Reticuloendothelial system
+ Marrow and probably all other sites
Nasal sinuses
Nasal sinuses
Larynx, lung
Nasal sinuses, lung
+
Endometrium
Vagina
+ Endometrium, gallbladder
Kidney (pelvis)
Skin, scrotum, lung
+
+
+
+ Breast
+ Ovary
+ Bladder
+ Liver (cholangioma)
+ Cervix uteri
+ Liver
+ Liver (hamartoma)
+ Mouth, pharynx, larynx, lung, esophagus, bladder
+ Skin, lip
Liver (angiosarcoma)
+ Liver (hepatoma)
° Expanded from IARC working group, 1980.
b By restricting this table to firmly established causes, we undoubtedly have omitted some of the
more important determinants of
human cancer. (A few borderline cases might not command uniform agreement; e.g., we have on balance
just included cadtnium and
just excluded beryllium.).
` A plus sign indicates that evidence of carcinogenicity was obtained&
d Certain compounds or oxidation states only.
` For example, from X-rays, thorium, thorotrast, some underground mining, and other occupations.
ture" and "nurture" but alAo "luck,"' or the play of
chance. "Nacurc" relittts to a person's genetic makeup
at conception, and this cerrtainJv affects the risk of
some types of cancer. For exarnple, other things being
tyuul!, a whitc-skinned person isanore likcly, to c)evelcup
skim canrcr in resptrnst to sunli~;ht tiran is a black-
skinnect l.>crson whiiY 1>tcrple who havc inherited xero-
derma pigmentosum, a very rare genetically determined
inability to repair the normal effects of sunlight on the
skin (:Robbins et al., 1974), are likely to develop several
skin cancers per person. "Nurture," which is the subject
of this whole report, relates to what people do or have
done to them (in the womb; in childhood, or in adult
life) and is of public interest as a determinant of cancer
J.Nct. vot-, 66. NO. u, JUNE t9ar

1204 Doll and Peto
risk because it is the only thing that can be influenced
by personal or politicali choice.'
Finally, "luck" takes care of the remaining differences
in outcome that both observation and theory lead us to
expect (Peto, 1J77b)i perhaps by determining the con-
catenation of events that brings about specific changes
in particular molecules in individual cells at particular
times. Somewhat similarly, luck involves some of us but
not others in traffic accidents. Even among genetically
identical laboratory animals kept under conditions that
are as closely uniform as possible, some will die of'f
cancer in middle age, while others will live on into old
age with no cancer. (t?.nalogously, the fact that some
people die of'. lung cancer at 40 years of age while other
people live on in apparently similar circumstances to
80 does not of ilself provide any suggestion at all as to
whether or not there are any genetic factors which
affecr lung cancer risks, for variation in age at onset of
disease would be expected in either case.)
Nature and nurture affect the probability that each
individual will develop cancer, and luck then deter-
mines exactly which~ individuals will actually do so.
However, although for each single individual the role
of luck is enormous, in a: population of a hundred
thousand or more (e.g., the population covered by one
particular cancer registry) the role of luck is smaller,
and in determining the annual number of cancers in
the whole United States Ittck has a completely neg-
ligible effect, for the larger the population the more
the good and bad luck will tend to average out. Conse-
quently, in the comparison of national cancer rates
only nature and nurture are important~ Much of the
evidence outlined above (changes of cancer incidence
with migration, changes over the decades within one
country;, and' the identification~ of particular causes of
cancer) points to an important role for "nurture."
However, this does not deny an equally important role
for "nature." For example, the stomach cancer risks in
certain countries differ markedly from each other, and
most are decreasing rapidly (table 5), both of which
observations point to the relevance of nurture. How-
ever, in both high-risk and low-risk countries people
whose "ABO" blood group (a factor that is determined
purely genetically) is of type "A" have a stomach
cancer risk some 209'o greater than that of their com-
patriots of type "0." In this instance, as for skin
cancer, nature and nurture seem to multiply each
' One difficulty of terminology with the disutxtion between
nature and nurture is where to classify a genetically inherited
tendency to behave in certaimm ways (e.g., to overeat or undereat):
From a public health point of view it is probably most appropriate
to attribute the net results of tendency-plus-beh:rvior ta "nurture,"'
since ftw such compulsions can he so rigid that social factors will
not also affect the behavior pattern. Another difficuGy in identifying
"nurture" " as "thar whit:h might Ixr avoidable"' is that sorne day
s<lective alionion. (or, more sfxeulatiivcly, wlecti've conception) may
Ik prrsilile to avoid thr birth uf a ftw babies wiih a near ccrtaioty of
druth tronr rauce.r.
other's effects. If many other genetic factors are relevant
to stomach cancer, then maybe two compatriots chosen
at random would be likely to differ quite widely in
their genetic susceptibility to the external causes of
stomach cancer, although it is still possible that there
is much less individual genetic variation than many
people suppose.8 Whether most Americans are of simi-
lar susceptibility or whether there is typically wide
variation in susceptibility makes little difference to the
net effects of changes in nurture on the total number of
cases in the nation as a whole and is therefore of little
immediate public health relevance. (In either case, if
the causes of stomach cancer are halved, then the
stomach cancer rates will be roughly halved, as has
been happening every 20 years.) Moreover, even if
individuals do vary widely in their genetic suscepti-
bility to stomach cancer, nhis does not suggest that
different countries will vary, widely in the averages of
the genetic susceptibilities of their citizens, for in each
such average all the large variations between com-
patnots will be ironed out. Fot a few types of internal
cancer the differences between countries may be chiefly
due to large differences in genetic susceptibility (e.g.,
the shortfall of chronic lymphocytic leukemia among
the Chinese an& Japanese or the excess of cancer of' the
nasopharynx among the southern Chinese), but this
seems likely to be the exception rather than the rule.
For example, taking the three types of cancer which are
currently commonest in the United States (lung, colo-
rectal, an& breast cancers); lung cancer was less than
half as common a quarter of a centuryy ago, which
shows that most cases are avoidable, while for both
breast and colorectal cancers there are striking corre-
lations between the rates in particular countries and
various aspects of those countries' life-style (e.g., fat
consumption; text-fig. 1), It is most implausible that
international variations in daily fat consumption are
chiefly determined genetically,, and if it is accepted that
they are not, then the striking correlations between
dietary factors and the onset rates of certain types of
cancer show that the large international differences in
onset rates are not chiefly genetic in origin. [Note that
these correlations merely suggest that these cancers are
r It is sometimes suggested that because a percentage of smokers
do not get lung cancer, there must be other catLses, or genetic
variability. The conclusion may or may not be correct, but the
argument for it is bogus. Conversely, it is often argued that because
the relatives of patients with a particular type of cancer have onlyy
moderate rather than marked excess risks of that type of cancer
(although no excess of cancer inm general);, the amounr of simplyy
inherited genetic susceptibility must also be moderate rather than
marked. This argument sounds reasonable, but in fact quite marked
genetic variation usually leads to surprisingly moderate excess risks
in relatives (Peto J, 1980)4 , so this argument too is bogus unless the
analysis is of people with two or more relatives affected by one
particular type of cancer (and makes tlue allowance for familial
sitnilarities in lifestyle and' environment). At present, the relevance
of genetic susceptihility to tlit cowttnon types of cancer rrtnains
obscure.
ea
JN(:I', VCJI. 66, NO. ti. .ft:Nt: 1981

Avoidable Risks of Cancer fn the U.S. 1205
A
50
>0
m
.ro.
..~ rt1
vlK . 'N .~ll
W. . Cr. -
.Co
~
.D0 on 120 tsD :a0 t.D :aD170.
ItR CAiUt,DAIEY MEAr CONSUMPttON- GAAM.S
rEnnAtE
.K.~faAW~
ers~ay
,~... ..«,.,..^
.~. .
.~.
a
t~
11L -0nG..u.w
C5
~..~.,~ ...~
...~.. ~,.,,,
om .Ofi0 00 too 120
B
TOT14 pETAftYFnT :NTGKE ( Fj / Doy 1.
t - - --- -
.
.~ 1,~
~rEXT-FlGURE 1'~.-A). Correlation between colon cancer incidence in
various countries and meat consumption (Armstrong and Doll,
1975a; reprinted with permission of British Journal of Preventive
and Social Medicine and R. Doll). B) Correlation between breast
cancer mortality in various countries and fat consumption (Carroll,
1975; reprinted with permission of Cancer Research and'~ K. K.
Carroll)j
These sviking, age-standardized correlations do not' necessarily
suggest that either meal or some type of' fat'are major determinants
o/ either colon or breast cancer, but they do suggest that mani¢
ulab& determi.nants of these cancers do exist-
Iargely avoidable (except perhaps among those few
people with the extremely rare genetic conditions of a
strong predisposition to colon cancer or to breast
cancer at an early age) but do not mean that avoidance
of dietary fao would achieve this.]
Turning finally to the role of age itself, it is
sometimes suggested that because cancer is ten or a
hundred times more likely to arise in the coming year
in old people than in young people,, aging per se
should be thought of as an important determinant of
cancer. We rather doubt whether this viewpoint is a
scientifically fruitful one (Doll, 1971; Peto et al., 1cJ75),,
and in any case we are concerned in this report with
avoidable causes of cancer, among which we can
hardly count old age.
3. PROPORTION OF U.S. CANCERS THAT
ARE KNOWN TO BE AVOIDABLE
If the foregoing is accepted :Is justifying the belief
that much huntan cancer is avoidable, tUen a crude
estimate of'~ the proportion of cases that might be
avoided in any tlne conttrtunity can lx obtained by
comparing for each separate type of cancer the inci',
dence in that community with the lowest reliable
incidence that is recorded elsewhere. For this purpose,
the calculation is best confined to figures for men and
women under 65 years of age, because the data on older
people are unreliable (see also Appendix C): The
proportion of avoidable cancers in older people is best
estimated indirectly (see below). For certain types of
tumor we have also thought it wise to omit rates for
those communities that are believed to have low rates
largely because of genetic insusceptibility. Finally, we
have omitted the common non-melanoma skin cancerss
entirely as, although they vary in incidence even more
widely than most other types of cancer, reliable figures
for their incidence are not generally available and they
are, in any case, easily treated and seldom fatal.
Before incidence rates in different communities can
be compared meaningfully, however, they must first be
corrected for the fact that some communities have a
higher proportion than others of young people (among
whom cancer is everywhere extremely rare). This is
allowed for by "age standardization," which we have
done by calculating what the incidence in each com-
munity would have been expected' to be if the propor-
tions of young people in each had been the same as in
the respondents to the 1970 ULS. census. Details are
given in appendix A, and age-standardized rates for
different communities can differ only if the incidence
rates observed among people of a given age really differ
between the different communities.
To estimate the proportion of all cancers that might
have been avoided, we have taken, as an example, the
population under 65 years of age in Connecticut
during 1968-72 and have compared the incidence of
each type of cancer (other than non-melanoma skin"
cancer) in that population with the incidence rates
recorded in the populations listed in table 7. For
example, the age-standardized rate for cancer of the
esophagus among men under 65 years of age in
Connecticut was 34.6 per million, while that in rural
Norway was only 6.5 per million. Similar calculations
were made for 37 other types (or groups of types) of
cancer in men and for 40 types (or groups of types) in
women. In selecting low rates, we confined ourselves to
data from about 1968 to 1972 from registries selected by
the IARC (1976) as being reasontrbly reliable.
The results are shown in table 7, and the total of
these low incidence rates is contrasted with the corre-
sponding totals for all types of cancer (except non-
melanoma skin cancer) in Connecticut and in many
other parts of the United States in table 8. The
comparisons in table 8 suggest that in most parts of
the United States in 1970 about 75 or 80 0 of the
cases of cancer in both sexes might have been avoid-
able. The proportion could be more, as the lowest rates
that have been used almost certainly include somee
avoidable cancers, especially since sornee of the countries
that differ most markedly in various ways from the
United States do not have a good cartcer registry and so
havee not beert uscd in table 7. (Nloreovcr, the propor
JNia. \'t)1-. lifi;, NU, ti. ll°Nk 1981.

1206 Doll an6 Peto
tion in 1980 will probably, be about one percentage
point larger than that in 1970 due to the steady
increase in tobacco-induced lung, cancer in the United
States.) However, the proportion that might by prac-
ticable means be avoidable may well be somewhat less
than is suggested by tabla's 7 and' 8, partly because in a
developed area such as the United States some lumps
may have been counted that, although histologically
"cancer," were biologically benign (appendix C); but,
more importantly, because even if means of modifica-
TABLE 7.-Cancer rates in selected low.incidenee areas among people under 65 years of age°'°
Male rates in: Registry, with lowest reliable incidence for: Female rates in:
Type of cancer Connect-
icut
registry Low-in-
cidence
registry
Males
Females Connect-
icut
registry Low-in-
cidence
registry
Lip 11.8 4.1 United Kingdom,
southern metropoli:
tan region United Kingdom;
Birmingham 0.8 0.4
Tongue 19.8' 4.1 New Mexico: Spanish Israel: Q Jews 6.7 2.7
Salivary gland 7.3' 2.3 Japan, Miyagi Japan, Miyagi 6.7 1.2
Mouth 31.3' 0.8 " " 11.8 2.4
Oropharynx 13.9 1.1 " " 6.0 0.8
Nasopharynx 11 5.6 2.4 East Germany East Germany 1.1 1.1'
Hypopharynx 10:7 1.4 " " 2.9 0.2
Esophagus 34.6 6.5 Norway, rural Norway, rural 8.3 1.8
Stomach 66:2 28.0 New Mexico: whites United States, Iowa 26.7 16.6
Smalli intestine 6,4! 3.0 Israel: Jews Israelc Q Jews. 5.0 2.5
Colon 137:2 13.7 Nigeria, Ibadan Nigeria, Ibadan 140.7 1L6
Rectum 98.6 14.1 "' " 66.1 17.2
Liver 11.8 6.0 United Kingdom,
southern metropoli-
tan region United Kingdom,
Oxford 5.3 1.0
Gallbladder, plus ducts. 9.0 3.3 Norway, rural Norway, rural 11.2 6.7
Pancreas 45.11 21.0 Nigeria, Ibadan Nigeria, Ibadan 30.9 14.9
Nose 3.2 2.2 United States, Iowa United States, Iowa 2.4 1.5
Larynx. 54!7 11.5 Japan, Miyagi Japan, Miyagi 8.2 0.4
Bronchus 325.8 9.0 Nigeria, Ibadan Nigeria, Ibadan 96,9 8.7
Bone 9.3 7.3 Puerto Rico United States, Iowa 7.5 5.2
Connective tissue 20.0 12.5 United Kingdom
Birmingham United Kingdom,
southern metro-
politan region 14.6 6.4
Melanoma 40.8 8ff United Kingd'om,.
Liverpool Uhited Kingdom,
Liverpool 38.6 18:4
Breast 3.5 1.7 Finland Israel: Q non-Jews 593.7 100:9
Cervix Israel: Q~Jews 90.4 42.5
Choriocarcinoma United Kingdom,
Oxford 1.2 0.2
Other uterine cancers Japan, Miyagi' 150.6 11.1
Ovary 104! 8 25.9
Other female genital organs 11 16.0 2.3
Prostate 92.3 5.3 Japan, Miyagi
Testis 26.6 7.1
Penis 2.0 0.2 Israel: Jews
Bladder 113.1 17:8 Japan, Miyagi Japan, Miyagi 32.8 7.3 0
Kidney 59:6 9;0 Nigeria. Ibadan Nigeria, Ibadan 23.2 2.5
Eye 4.3 2.0 Japan, Miyagi Japan, Miyagi 4.3 0.5
Brain and CNS 54.9 12.2 " " 35.2 8.9
Thyroid 12.4 3.6 United Kingdom,
southern metropoli-
tan region United Kingdom,
Oxford 34.0 8.8
Other endocrine cancers 2.5 1.4 Puerto Rico Puerto Rico 2.2 0.6
Lymphosarcoma 39.8 13.1 " " " " 25.5 6.4
Hodgkin's disease 37.4 6.2 Japan, Miyagi Japan, Miyagi 28.1 3.5
Other reticuloses. 11.3 1.8 Israel: Jews Israel: 9 Jews 7.6 1.9
Myeloma 15.1 1.8 Japan, Miyagi Japan, Miyagi 9.6 3.3
Leukemia 57.9 40.8' New Mexico: Spanish " " 41.1 36.3
Polycythemia 4.8 0.6 Japan. Miyagi " " 1.6 0.3
All other cancers 89.9 33.7 New Zealand: whites New Zealand: whites 74.6 23.5
Total, all cancers
1,590 321
1,775 408
' For all tumors except those of benign or unspecified malignancy an& non-melanoma skin cancers
(which, collectively; accounted
for <2% of all cancer deaths in the United States in 1978).
° From IARC (1976).
` Annual rates/million people <65 yr old, standardized for age as deseribe& in appendix A.
JNC. vOt.. rA. hc). 6. Jt7Nt 1981

Avoidable Risks of Cancer In the U.S. 1207
TABLE 8'-Com}tarison of total'tumor incidence rates'6 abserred
in various American cancer regist'ries, circa 1970'
Area in United Male tumor
incidence Female tumor
incidence
States covered
bv tumor
registry°
Observed
Minimal,'
as % of
observed
Observed
Minimal,'
as % of
observed
Alameda, Calif. (W) 1,589 20 2,108 19
San Francisco,
Calif- (W) 1,668 19: 2,137 19
Connecticut 1,590 20 1,775 23
Iowa 1,422 23 1,594 26
Detroit, Mich: (W) 1,498 21 1,737 23
New Mexico (W) 1,469 22 1,784 23
New York, upstate 1,372 23 1,481 28
El PasoTex. (W) 1,245 26 1,682 24
Utah 1,215 26 1,464 28:
"Ten areas" from TNCS (a study covering a modtrately
representative tenth of~ the whole United States):
TNCS White 1,519 21 1,702 24
TNCS Non-white 1,906 17' 1,721 24
TNCS White
and non-white 1,557 21 1,705 24
` Annual rates/million people <65 yr old, standardized for age
as described'& in appendix A.
° See table 7, footnote a, for excluded tumors:
" The totall of the lowest reliable rates for each type of cancer
listed in table 7 was 321 (a) and 408 (Q), which is a crude indi-
cation of the minimal incidence that might be achieved.,
° W=whites only:
avoidable may simply be tiie proportion that is avoid-
able among middle-aged people.
The foregoing estimates refer to all, malignant tumors,
both fatal and non-fatal' (excluding only non~rnela-
noma: skin cancer): Directestimation by similar methods
(but on the basis of national, death certification rates
instead of, as in tables 7 and 8, registered incidence
rates) of the proportion of fatal cancers that are
avoidable might be misleading. This is because many
underdeveloped countries enumerate causes of death so
inaccuratePy that comparison of their certified death
rates from particular types of cancer witK the corre-
sponding rates in the United States might overestimate
the proportion of U.S. cancer deaths that is avoidable.
However, the two types of cancer (lung and' large
intestine) that currently kill the largest numbers of
Americans have incidence rates that vary particularly
widely between the United States and certain other
countries and the U.S. deaths from these two types are
therefore largely avoidable. The same is true of many
other types of cancer that currently kill large numbers
of Americans, and it is reasonable to suppose that the
proportion of fatali cancers whose onset could have
been avoid'ed' will be approximately the same as the
avoidable proportion of all cancers discussed above,
i.e., more than 75 or 80 o in principle but perhaps less
in practice for many years to come.
4. ATTRIBUTION OF RISK
tion of cancer risks can be identified, these may not be
socially acceptahlt. This might obviously be a seriouss
limitation if preventive measures had perforce to be
limited to ways whereby different countries already
differ,, for affluent people will not be persuaded to
ad'opt certain aspects of the life-style of the impover-
ished. But there may be many different simple or
highly technical ways of preventing the same cancer
(see subsequent sections), some of which have not been
inadvertently adopted by any country with a good
cancer registry, at least one of which ways may be both
practicable and acceptable.
About half of the cancers diagnosed in the United
States are found among people 65 or more years old,
and we have made no explicit estimate in table 7 of
what proportion of these might be avoidable. This iss
because data from cancer registries become very unreli-
able in old age, not so much in the United States
nowadays as in those countries where the contrasts
with the U.S. life-style and environment may be
greatest. Consequently, any similar analysis of rates
among older people might be severely biased. There is,
however, little reason to suppose that the proportion of
Li.S. cancers that would be preventable differs greatly
above and below the age of 65 years as long as lungg
cancer (which is relatively slightly tnore comrnon
among the old)i and other cancets are considered
separately (see sr(tion 5:1 and appendix 1:): f'ara-
doxically, thcnfrrtc.;, rhc most reli:rble available rstitnate
rrf; tttc propur,ir)n of c:utccr :rrnonf; oltlcr fxoplc that is
4.1 Increases and Decreases in U.S. Cancer Rates
If there were currently an "epidemic" of cancer in
the L'nited States (by which we mean rapid increases in
the probability of people of a given age developing
most particular types of cancer), this might suggest
that the search for avoidable causes for the cancers that
we observe today should be directed chiefly toward
various aspects of the modern environment that were
much less widespread half a century or more.ago. If,,
conversely, most of the cancers that are now common
have been common for many decades, then, although
this would not be evidence as to whether our new
habits will eventually increase or decrease future cancer
risks, it might suggest that the cancers that are cur-
rently common, and that will continue to be common
unless we do something about them, have been largely
determined by long-established aspects of the AmericanN
life-style or environment. ,N~
Practical Difficulties in Gauging Cancer Trends
Cancer is certainly much more noticeable nowadays
than it was a decade or two ago, bur this is not in itselfi
evidence that cancer rates are increasing as there art~
several factors that influence public awareness abou
cancer. First, especially when active treatment is bein
undertaken, the friends and' relatives of cancer patient
(or the general public, if the patient is a public figure)
nray discuss the disease openly, whereas previouslv
such~ matters often used to be hushed~ ttp and the
.)NCt. VOt.. u,: NO. 6. JUNt_ 1981

1208 Doll and Peto
TABLE 9. Deatie certification rates/1,000 Americans,°
1935 and 1875
All neo-
piasmsb Respir-
All causes
except except atory
' All causes
Sex Years neoplasms respir- tract
atory cancers
cancers
Rate 'lu` Rate %` Rate 91i` Rate %`
Male 1933-37 15:12 91.0 1.42 8.5 0:09 0.5 16.63 100.
1973-77 &91 81.0 1.41 12.8 0:69 6_2 11.01 100'
Female 1933-37 11.92 87.6 1.65 12.1 0:03 0.2 13.60 100
1973-77 4.96 78.8 1.17 18.6 0:16 2.5 6.29 100
"' All ages, standardized for age to U.S. 1970 census (see ap-
pendix A). For most scientific purposes, separate examination of
the trends above and below the age of 65 is preferable (see ap-
pendixes C and' D);, since many deaths from cancer half a cen-
tury ago may have been miscertified as due to other causes;,
particularly among older people.
°' Benign ar.d malignant tumors are included'in this table, as
elsewhere throughout this text.
` Rate as percent of corresponding all-causes rate in last
column:
diagnosis perhaps withheld even from the victim.
Second, some cancers are now diagnosed that might
previously have gone unnoticed in the medical treat-
ment (and subsequent death certification) of dying
people, especially of the elderly. Third, cancer has
become relatively more common as a cause of'~ death
chiefly because of the prevention or cure of so many
other diseases. This is nicely illustrated by the data for
0.8%
0.7.
x 0.61
h
t
WW
D<
.5%
Y Y
q 4:
~M 0.41
6 0
~~ 0,39
2z y
4
0.21
0.1.
DECREIISING 110N-IteSPIR/1TORy C7INCER.. yENAllS..
DECREJISING
VASCULAR DISEIISESINCE.1970
'--+---~..
..
L
fS/r11A70NYfJJCOI (N)
- - - - - 11rs.rWl7onT cwNCeR (r)
1935 1940 1945 1950 1955 1960 1965 1970, 1975
CGrlSTJWT N0M-RESPIRATORY
CENT.iA:. YE/WI
(centrek y..ro! 5-ye.r period tadled, 1933-37 to 1973-77)
7}:xr-r1cuRl: 2.-Annual aKe-swndardiitd dialh ra(es I'J9'3-77, anhong Americans under 65 years
of agc.
CJINCBR
NP
LBSS
females in 1935 and 1975 (table 9). The non-respiratory
cancer death rates decreased substantially, but the death
rates from all other causes decreased even more sub-
stantially. Therefore, the percentage of female deaths
attributable to non-respiratory cancer is actually greater
now than it was 40 years ago, even though among
women of a given age the absolute cancer risks are
lower nowadays. If attention had been restricted to
people under the age of 65 years (text-fig. 2); then the
contrast between declining absolute rates and increasing
percentages would have been even more marked. Fourth,
there is a larger proportion of old people nowadays,
and cancer risks are ten or a hundred times greater
among old people than among young people. Finally,
cancer has become a highly political issue, and con-
sequently discoveries (perhaps using modern ultrasen-
sitive analytical methods) of even quite small amounts
of carcinogens in various everyday contexts attract
vigorous media coverage, as d'o various other aspects of
cancer research.
We shall therefore review in this section, and in
our appendixes C, D and E, some of the objective
evidence concerning the upward and downward trends
in the U.S. death rates from, and incidence rates of,
various cancers. Epidemic increases in lung cancer are
clearly taking place, as would be expected as a result of
the widespread adoption of cigarette smoking earlier
this century, but apart from this we can see no good
evidence of a cancer "epidemic"' in the above sense.
Unfortunately, both cancer registration rates (a "can-
cer registry"' tries to count all the new cancer onsets in
a particular area,, such as the State of Connecticut) and
cancer death certf fication rates are subject to large
JNCI, VC/l.. (7;, NO. (:, JUtNF:. 1981

errors; more unfortunately, these errors are not con-
stant witK time so that artifactual trendsin theregistered' incidence or certified mortality rates
for
particular cancers may be superimposed on the true
trends. The problem with:any comparisons of cancer
rates in different decades is that these artifactual trends
may be of the same order of magnitude as the trends in
real cancer onset rates that one wishes to study. The
chief sources and likely magnitudes of such biases are
discussed in appendix C.
Reduction of Bias: Trends in Mortality in Middle Age
The data suggesting moderate improvements in rela-
tive 5-year survival rates (e.g., from 60 to 68% for breast
cancer)i are also discussed in appendix C(see table C2
on page 1278); where it is suggested that parr at least of
these moderate apparent improvements is artifactual,
due to progressively more complete enumeration of the
non-fatal cases. Changes in treatment for many types of
cancer have chiefly improved palliation rather than cure
of the disease, and the true cure rates for many of the
common types of cancer have probably changed very
little since 1950. For these types of cancer the trends in
death certification rates among people under 65 years
of age, at which ages treatment of the curable and
medical investigation of! the causes of death of the
incurable have for decades been reasonably careful,
may paradoxically y,ield' a mucK more reliable (and
representative) indication of the real trends in cancer
onset rates than can the superficially more attractive
study of any of' the currently available data on registered
incidence rates. The need to restrict attention to death
certification rates for people under the age of 65 years
arises because many people who died of cancer in past
years never hacf' their disease diagnosed and might have
been certified as dying of pneumonia, senility, or the
wrong type of' cancer. Progressive correction of such
errors over the past several decades has resulted in large
artifactual trends (some upward, some downward) in
the death certification rates for certain types of cancer
especially during the first half of this century or, since
1950, especially among old people. (These and various
additional biases also affect the trends in disease
registration rates, where a registry tries to count both
all fatal and' non-fatal cases of cancer: see appendix C.),
However, for most types of cancer the trendk since the
1950's among middle-aged American death certification
rates seem likely to yield a reasonable indication of! the
true underlying trend's in the corresponding real dis-
ease onset rates.
Increase in Middle-Aged Mortality From
Respiratory Cancer
Either by examining the lower lines in text-figure 2
with a magnifying glass, or by referring to appendix
tables I)1 and D2 (pp. 1282-1283) from which text-
figure 2 was derived, it can be seeu that rnale respira-
tory cancer death rate.s appear to h,tve been rising
stc~~adily for at Icast half a ce.ntrary and that fernale
Avoidable Risks of Cancer In the U.S. 1209
respiratory cancer death rates started to rise a quarter of
a century ago and are now increasing alarmingly
rapidly. The trends in respiratory cancer are discussed
in more detail in appendix E, where we conclude that
before 1950 airitost the whole of the apparent increase
in female lung cancer and some of the apparent
increase in male lung cancer were artifactual, due to
more accurate detection of lung cancer, but that some
of the pre-1'950 male increase and virtually all of the
more recent increases in both sexes are real and are
largely or wholly caused by the delayed effects of the
adoption, decades ago, of the use of cigarettes (see also
section 5.1). (The long delay between cause and full
effect arises because even among people who have
smoked regularly throughout most of their adult livess
the degree of exposure of the lungs to cigarette smoke
during their late teens or early twenties remains a
surprisingly important determinant of~ lung cancer
risks in middle or old age. See text-fig. El on page
1292.)
Lack of Generalized Increase in Middle-Aged Mortality
From Non-respiratory Cancer
Text-figure 2 and tables D1 and D2 (pp. 1282-1283)
also indicate that the aggregate of all non-respiratory
cancers has takem a fairly constant toll among males for
half a century (with about a 10% decrease among
younger men in the past decade), but that the total
non-respiratory cancer death rate among females has
been decreasing rapidly for half a century, due not
chiefly to improved treatment but rather to d'ecrease&
onset rates among women of a given age. For age-
specific details, see text-figs. C1 and C2 on page 1272.
(All the overall comparisons we make are based on
"age-standardized" rates, which can change onlyy be-
cause of changes in the risk of cancer among people of
a given age; increases or decreases in the proportions of
old people will not affect them. This is not true of
"crude" cancer rates nor of "percentages of all deaths
attributable to cancer," and these should never be used
to characterize trends: see appendix A.) However, non-
respiratory cancer is an aggregate of many completely
different types of'~ cancer, some of which are increasing
and some of which are decreasing.
Text-figures 3 and 4 describe, for males and for
females, respectively, changes in mortality (or, more
strictly, death certification rates) during the past quarter
century for various types of cancer. 14oree detailed data
are presented in table D3 on page 1284, together with a
separate discussion of the apparent changes in mor-
tality from various particular types of cancer among
people under 65 years of age. Corresponding details for
people aged 65 years and over appear in table D4 on
page 1285. A11 the changes are small in comparison
with the large increases in the smoking-related cancers
of the respiratory and upper digestive tracts, although
the decreases in mortality from cancers of the stomach
and uterus are also important.
ln apfxndix I) we also present the recent (Jf1(i8-"!ti)
trends in drath svrtificatiotr rates among Arnericans in
Jwct: vt,t.. ta;: NO. t;. )tt.rvt: t9r'<t

1210 Doll and Peto
ROIR'H.
iSOPAGbS
PHARINX
OR LARYNX
LUNG
STOtlACH
INTESTINES
(INC. RLCTUM)
LIVER. GAI.i.
BLA'JDER BILE
DUCTS
PAN'CREAS
BONE
SttiN
BLADDER
1lIDNEY
PRUSTATi
BRAIN
NERInOS
itUKA1:HIA
r
"J'
~
HODGKIN'S
DISEASE
& MORTALITY
-7
XeY ~ 1 195%JJ+]
19)J+7
Hale., age 0, 6Iyeera,
certlfled nortallty
OIHER RETICULO-
EN7()'71:ELI.4
OTHER A(@+Ir:EIY
UNSPECIFIED
SITiS
TEXT-FIGURE 3-C:ertified mortalitr^ per 100 million males, ages
0-64 years (standardized for age to U.S. 1970 population as de-
scribed inI appendix A):
early middle life (35-44 years of age), as it is here that
the first effects of'any changes for better or worse in the
causes of cancer might first be clearly evident. Reassur-
ingly, no unexpected upward trends emerge (see table
D6 on, page 1287), while significant downward trends
are seen ini mortality from many types of cancer. For
males, the sites where there are now significant de-
creases in mortality at, ages 35-44' years include the
pancreas, lungs (presumably chiefly due to decreasing
tar yields per cigarette: See appendix E), and genitalia.
For females, they include the intestines, genitalia,
reproductive system, and breast (~the latter decrease due
perhaps to a protective effect of early childbirth on the
mothers of the 1950's glut of'babies). Overall, cancer
mortality among young adults in the United States is
decreasing quite rapidly, and much of the decrease
cannot plausibly be attributed to improved therapy.
Trends in Incidence, as Assessed by
Cancer Registry Data
"I'urning (with some trepidation, because of the
greater likelihood of bias) from trends in certified
mortality to trends in registered incidence, we are
immediately confronted with the problem of exactly
which incidence data to study-those from particular
cancer "registries" that have operated for decades,
trying to list all the cases, fatal or otherwise, of cancer
in New York or Connecticut, those from comparison
of the Second Natitlnal' (:'tncer Survey (SI\r(S) in
1947 or 1948 with the Third National C»icer Survey
(7'\C:S1 in 1969-71, or those from comparison of the
-I-\CS with the Surveillance: Epidemioli;y, and End
Rc-sults (SI`F.R) pn)l;rarrr of the rnid-197(1's' (.SN(.S,
0 2000 6000 10 800, 15 000 70000 25000 30 000
I ( I I t~~. I'~. I r 1
ESTIMATED RaTES
AMONGNON-SMDKERS
TNCS, and SEER all tried to monitor cancer incidence
in about one-tenth of the entire U.S. population.)
Unfortunately, many, of the above comparisons suffer
from such large artifactual irregularities and biases (see
discussion in appendix C and text-figs. C3 to C5, pp.
1274-1276) that for most types of cancer they yield
much less reliable information about long-term trends
in real disease onset rates than the mortality data do.
The only one of these comparisons of cancer inci-
dence rates that is at all compatible with the mortality
data is than of the SNCS (in 1947 or 1948) with the
TNCS (in 1969-71). This comparison has been de-
scribed by Devesa and Silverman (1978, 1980). From
their 1978 paper we have abstracted text-figures 5 and
6, describing the changes in registered incidence rates
for each of the major types of cancer. The overall
pattern of change indicated by these text-figures is, of
course, roughly similar to that indicated by the mor-
tality data, for this was why we selected! this particular
comparison of incidence rates for study. Consequently,
we would not strongly disagree with anyone who
argued that even the comparison of incidence rates in
text-figures 5 and 6 is so uninformative that it would
be preferable to rely chiefly, on mortality data (although
some of the striking differences. between certain of the
trends in incidence may be informative as, for example,
the apparent decrease in cancer of the cervix but not of
the endometrium).
MOUTH,, ESOPHAGUS,
PHARYN% OR LARYNX
LUNG
STOMACH
INTESTINES(INC.
RECTUM)
LIViR, GALLBLADDER
AND BILE DUCTS
PANCREAS
BONE
SKIN
BREAST
BLADDER
KIDNEY
CERVIX UTERII
ENDOMETRIUM AND
OTHER UTZR:`S
OVARY
BRAIN AND NERVOUS
LtUxAEMIA
HODGKIN'S DIStASE
OTHERRCTICULO-
ENDOTHELIAL
0 2000 6000 10 000 15 000 . 20 000
I I I I I li I I
~ ESTIMATED RATES
AdOHGNON-SMOKERS
~P
.]
y MORTALITY
r
~
Key
197)-7
Female, age 0-64 years,
certtfled RR:r2ality
OTHERAND (CHIEFLY
UNSPECI~F'IEDSITES
TF.xt;FictfRe. 4.-Certified monality per 100 millinn females, ages
0-64 years (stmdardiztnl for age to U.S. 1970 tx/pnla11U11 as de-
xrilxd in aptxmdix A).
J\(SL VOL. (a6;, NO. b. 11'1~F~. 1901
~.

Avoidable Risks of Cancer In the U.S. 1211
lqUTH ESOPHAGUS,.
PH,ARYNX OR LAR:Y NX.
LUNG
STOMACNINTESTINES.(r.NC.
RECTUM)
LIVER, GALLULADDEA
IUIDD aSLE DUCTS
PANCREAS.
HONE'
MELANOMA
ULADDER
KIDNEY'
PROSTATE
BRAIN AND NERVOUS
KAEMIA
EU
0 100 200 JUD, 400 50D 600700 '
I 1 t t 1 1 t t
J
]
t
d INCIDENCE
Key~ snCS, 19oYB'
TNCS, 1969-71'
L
. Mste.,. alli
aqes,
registeredlncidence
HODGKIN'S'. DISEASl:
OTHER IIETICULO-
[NDOTHE I.I AL
OTHER AND UNSPEC-
IFILD SO:iID, EXCEP~TSKIN
TExT.Ftcvae 5.-Registered incidence rates per million males, all
ages' (st-tndbrdized for age to U.S. 1950 population and for race to
90~'a white).
However, even if the detail of the incidence trends is
uncertain, the general picture is clear: a) the most
important absolute increases have been in cancer off the
lung, b) the mosr important absolute decreases have
been ini cancers of the stomach andl uterinecensix, and'c) less reliably, there seem to be no large
changes in
the aggregate of the incidence of all nonrespiratory
cancerq(for which the age-standardized incidence regis-
tration rates d'ecreased! between 1947-38 and 1969-71 by
3% for males and' by 19% for females.).
Comparison With Interpretations by Others
ln suntmary, the trends since 1950 in mortality in
middle age, sornewhat reinforced by, the trends in
incidence between the Second and Third National
Cancer Surveys, suggest that, apart from the effects of
smoking (and perhaps asbestos: See section 5.6), there
are no major epidemic increases in cancer. Unfortu-
nately, our conclusion is not shared by all commen-
tators. Epstein (',1981b)) whose book, TheYofil':c.sofCancer10 (Epstein, 1978, 1979), was based on
the
° N!e have'e!xcdudrd; sinre ttie surneyti did rtot attcrnpt to register it;
non-mrlanunta skin cancer, Non-ntclanoma skin cancer is diagnosed
mort contntunly than any othrr type of c:utcer, but it is nearly
always so easily cured that it is one of' ttie Ic:tst common fatal
ca nccrs.
lo' For a wide'-ran/;in}; cumm(nt on Epstein's (1978, 1979, 1981a,
198115) lxrslxctive on (hr caustsol eanrer, which will make clear our
reasons fnr rtot drlwing on it in uur present report, srr Peto. I980!
The par(ieular qur'stiun of thc rol( nf cxcupatii)n:J la((ms will la+
dealt with in wcti(/n rr/i' :/nd apfx ndix F, where s(ronl; reasons fln
distruti(inl; F:ps(ein'. 11!IR1aai) suw(r. :uw y;iv(n:
assumption that Americans live in an era of genuinely
and rapidly, increasing cancer rates over and above the
increase dite to tobacco, rejects in out of hand without
acknow1'edging or explaining wh. the trend in U.S.
mortality from non-respiratory cancer in middle age is
actually downward, and without serious discussion of
the potentiali biases in trends in death certification rates
among older people (or, still' more so, in trends in the
registered incidence rates of tumors) that we have
emphasized' in appendixes C, D, and E. The Toxic
Substances Strategy Committee (TSSC) in their 1980
report to the U.S: President also came to a conclusion
directly opposite to ours, namely, that "even' after
adjustments for age ... recent figures show that both
incidence (new cases) and mortality (deaths) rates are
increasing," and later that "when the effects of cigarette
smoking are corrected for, the recenu trends in incidence
show an increase." Their conclusions about rising
incidence rates were based on the data of Pollack and
Horm (,I980)1 and on the interpreration of these data by
Schneiderman (197'9) and rested heavily on a com-
parison of the incidence rates recorded in the TNCS
during 1969-71 with those recorded in the ongoing
SEER program that began in 1973. In appendix C we
show that this particular comparison yields estimates
of trends in reali disease onset rates that are grossly
discrepant with more reliable data.
An even more serious error in the TSSC (1980) report
is the committee's peculiar method of "allowing" for
the effects of! cigarette smoking on the recent trends in
MOUTK, ESOPHAGUS.,,
PNARYNX..OR LARYNX
LUNG
STOMACH
INTESTINES (INC.
RECTUM)
LIVER, GALI~tLADDER
AND BILE DUCTS
PANCREAS
BOME
MELANOMA
BREAST
BLADDER
KIDNeY'
CERVIX',UTERI
ENDOMETRIUM AND
OTHER UTERUSOVARY'
BRAIN:ANDNERYOUSIEUKAEMIA.
xODGKIN'S DISEASE
OTHER RETICULD-
F:NDDT)IELIAL
Ot'NER.AND tN'SPL'C-
I PI ED S0L1 D,
EXCEPT SKIN.
J
~
8
100 200 300 400 500 600 700
1 II I I I I I
1
Key
Q INCID$NCE
~ sMCr, 1W7/B'.
TKt, '.%9-71'
Penrl., all aqe.,
reqlstered', 1nclA.nce
TEX7'-rtctleE 6.-Rtgistertd'' incidence r:ues per million feutales- a1l
ages (standardinYf for age to U.S: 1950 fxlpul:uion artd for race to
90°. white).
a\fa. VUl.. tli, 1t). (r; JtrRl:' I!IN1i
